Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. - Wikidata - wikimedia - TriplyDB

Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production.

Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production.

http://www.wikidata.org/entity/Q36936364

about

The Potential Protective Effects of Polyphenols in Asbestos-Mediated Inflammation and Carcinogenesis of Mesothelium Mitochondria: a new therapeutic target in chronic kidney disease Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptor Long-Term Effects of (-)-Epigallocatechin Gallate (EGCG) on Pristane-Induced Arthritis (PIA) in Female Dark Agouti Rats Green tea polyphenol treatment is chondroprotective, anti-inflammatory and palliative in a mouse post-traumatic osteoarthritis model.Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis Blocking ERK-1/2 reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein A Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise Rose hip and its constituent galactolipids confer cartilage protection by modulating cytokine, and chemokine expression.Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome Current nutraceuticals in the management of osteoarthritis: a review Epigallocatechin-3-gallate attenuates Porphyromonas gingivalis lipopolysaccharide-enhanced matrix metalloproteinase-1 production through inhibition of interleukin-6 in gingival fibroblasts.EGCG attenuates autoimmune arthritis by inhibition of STAT3 and HIF-1α with Th17/Treg control.Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected].Epigallocatechin-3-gallate suppresses the global interleukin-1beta-induced inflammatory response in human chondrocytes.Blocking of interferon regulatory factor 1 reduces tumor necrosis factor α-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein a: role of the nuclear interferon regulatory fa Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis.Impact of tea drinking upon tuberculosis: a neglected issue.Pathological role of fractalkine/CX3CL1 in rheumatic diseases: a unique chemokine with multiple functions.Thymoquinone inhibits TNF-α-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation.Celastrus and its bioactive celastrol protect against bone damage in autoimmune arthritis by modulating osteoimmune cross-talk EGCG Prevents High Fat Diet-Induced Changes in Gut Microbiota, Decreases of DNA Strand Breaks, and Changes in Expression and DNA Methylation of Dnmt1 and MLH1 in C57BL/6J Male Mice Largazole, a class I histone deacetylase inhibitor, enhances TNF-α-induced ICAM-1 and VCAM-1 expression in rheumatoid arthritis synovial fibroblasts.H-2g, a glucose analog of blood group H antigen, mediates monocyte recruitment in vitro and in vivo via IL-8/CXCL8.Recent advances in neutralizing the IL-6 pathway in arthritis.Green tea and exercise interventions as nondrug remedies in geriatric patients with rheumatoid arthritis.Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K(63) -Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6.Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications.Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis.Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.Epigallocatechin-3-O-gallate inhibits the production of thymic stromal lymphopoietin by the blockade of caspase-1/NF-κB pathway in mast cells.Green tea EGCG, T-cell function, and T-cell-mediated autoimmune encephalomyelitis.An update on dietary phenolic compounds in the prevention and management of rheumatoid arthritis.The therapeutic potential of plant flavonoids on rheumatoid arthritis.MicroRNA-17 Suppresses TNF-α Signaling by Interfering with TRAF2 and cIAP2 Association in Rheumatoid Arthritis Synovial Fibroblasts.Down-regulation of myeloid cell leukemia 1 by epigallocatechin-3-gallate sensitizes rheumatoid arthritis synovial fibroblasts to tumor necrosis factor alpha-induced apoptosis.Epigallocatechin-3-gallate reduces airway inflammation in mice through binding to proinflammatory chemokines and inhibiting inflammatory cell recruitment.Managing Rheumatoid Arthritis with Dietary Interventions.Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis.Tumour necrosis factor-α-mediated disruption of cerebrovascular endothelial barrier integrity in vitro involves the production of proinflammatory interleukin-6.

P2860

Q26750451-E930B67F-F99B-46B6-837F-F6EE7FE70B17 Q26776397-CFA96422-F2AA-4D83-8901-EC96718D59CF Q27022976-FA10D4F9-68EF-4B27-BC3E-6E2AA3D26109 Q27316058-1BA37A31-19AB-48A7-BB3E-33E89F9EED7C Q30622479-2DCC54FD-C58E-4E3E-811E-65908C159926 Q33646334-24615CBC-9AFD-4C31-ADB5-669194EA5F5A Q33793186-AB91DCD2-006F-4A4C-BA7B-A5AEBC550C6A Q33923444-5FFA3CF7-0865-4788-ACC6-12B24AD6DDC7 Q34066453-F507A191-C460-4524-A84D-295F24F0D4C1 Q34185567-4604BFE4-F58A-4749-8614-9687AF6B9BF6 Q34291608-9DCABEED-2D9A-4C4F-B134-8B57883C34F1 Q35038327-1798E12B-AA99-471D-8384-00406E6F2C1E Q35099449-B7462AE6-C412-46A9-93D3-32EC1D959DC6 Q35135845-771C41B6-666E-4136-AF8F-20B6F9F1FFEE Q35557911-4044516B-6A43-4AD8-9910-C775C3574771 Q35559075-546AAFF5-AAE3-4805-9D33-750C25E2FD1F Q35620315-74DDEF03-FF58-4C53-9CDF-5E552AD4A4E6 Q35645396-E5D7764E-80B1-4361-9F5A-A6520739539D Q35927383-7AFF0020-9F62-4BD3-948B-344CA7FC76AF Q35995435-E4653ADB-2F6E-458B-958B-AD26CE440BF1 Q36052535-9E8B2420-6418-4DE2-AD0F-8ECE2A7FF905 Q36263446-2D2EAB5D-9CC2-4BEE-9DBA-62B03394C98E Q37155203-1FF55CBA-C6BD-4866-9F4B-38D47B157E17 Q37301165-77B00725-B846-465E-BB65-1D5DC4822D88 Q37358099-716206FA-0827-413A-BDBB-EC9815305C0A Q37382183-B79B8852-7438-40C4-BF62-637C55BA2CD7 Q37740229-BF871EBA-5A68-467C-A15F-6E0A36DEBCE8 Q38120159-F65C333C-1ED6-4357-AA10-5E1D79E7B9C6 Q38122932-406AA7DB-8D88-4EF4-B655-6CE1C5DBFC3B Q38183314-FF35AAF0-AB0E-4DB6-8BA3-EA749AD933B5 Q38471521-65A1CFE1-9BF0-40FC-BEC6-4C1E9FE6210C Q38830645-E4A783BC-89C4-47F6-8F60-49BDD09B3B85 Q38854028-6F449FD2-9EEB-4343-B592-B5AEF76E3840 Q39016582-0C7B97BC-3319-49BA-982E-EFD9B453F9D3 Q39481105-B43D0A5C-97E5-4B20-9D7E-250A94F94B03 Q41838784-D6E5624E-12FE-4A8C-9648-9CF26FE93374 Q42280341-B9B99645-230E-4FED-9336-89B9F48DD0A9 Q46114963-964AF517-7FEF-4148-8737-373D7C0043C8 Q46257779-E5969BEF-12CF-4840-8895-D05AE2F01443 Q46649192-99D02368-330E-49CF-B6BF-746AEB8DA2E0

P2860

Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production.

http://www.wikidata.org/entity/Q36936364

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Epigallocatechin-3-gallate inh ...... cing soluble gp130 production.

@en

type

label

Epigallocatechin-3-gallate inh ...... cing soluble gp130 production.

@en

prefLabel

Epigallocatechin-3-gallate inh ...... cing soluble gp130 production.

@en

P1433

Q36936364-36BDD342-8896-4D3C-AC0D-AB5FDA2E5E0E

P1476

Q36936364-8CA8B287-C8D0-4F19-8715-F2BD63EADE5D

P2093

Q36936364-03FCC2EC-609D-4F0C-A4D9-DD20EEE077F2

Q36936364-6BBFCB06-5FF9-4E3D-AC25-F17420E4292E

Q36936364-900683A5-D4EA-40E2-AF82-F071C0132D36

Q36936364-CA69301D-D4AE-42E7-B2F8-D5262F3CD09C

Q36936364-CAE5FCE8-F5EF-428D-ACFF-AE22C96B9F9C

Q36936364-CC32E3B2-681D-48B1-8B8B-91B3D1B9CFC7

Q36936364-ED6512F0-82FD-4B8A-A45A-E9AC19C9AF19

P2860

Q36936364-109915CF-B232-41ED-8A22-8191DDA61F1B

Q36936364-157F89D9-E659-460E-B663-F309E3BAADF0

Q36936364-2239E9F9-7BB4-4B6B-9DD2-A3F9FEBDF850

Q36936364-2580EE75-C531-465F-84DC-6369EF45FEDA

Q36936364-2777ED26-6C5A-4DC7-96F5-AF2AC2E706D0

Q36936364-2AC27793-F759-4A94-B026-738271B15CF3

Q36936364-2E19AF01-D867-4AA5-8EE8-CC7065F2EBBC

Q36936364-3DBE609D-FB5B-408D-AC3B-CA9E1FBD223B

Q36936364-47500245-7CEA-4EE1-A3CA-36B4FB8C3656

Q36936364-49E43FFE-1F4C-403D-B3D8-C5CB11E972B5

P304

Q36936364-BF88BD7C-4BD2-4B4F-8924-96E0E03AE05F

P31

Q36936364-2E973FBB-8386-4745-A1BD-80B66709140C

P356

Q36936364-B71CE48D-B916-4303-9EF4-39E04FAB49BC

P407

Q36936364-C841C1B4-5C33-450E-9875-C9E5FC076310

P433

Q36936364-19B4A96C-08F4-47F9-A714-3558B937E2D9

P478

Q36936364-0968ACE6-09CE-4641-A014-92951D9BF2FB

P50

Q36936364-975E6D6E-0C7A-446F-990A-91EED9299DA1

P577

Q36936364-5DD0B473-7D61-413A-A8B3-4919F08C3F05

P5875

Q36936364-28D84DDF-02B7-4399-9299-FB9189E6B66E

P698

Q36936364-BC5945F4-4510-40A3-9ED6-1ED0802251BA

P932

Q36936364-D798A5F3-A439-4A41-8073-F3D13BC6CBA5

P356

PNAS.0802675105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Epigallocatechin-3-gallate inh ...... ncing soluble gp130 production

@en

P2093

Alisa E Koch

http://www.w3.org/2001/XMLSchema#string

Angela Pakozdi

http://www.w3.org/2001/XMLSchema#string

Bradley J Rabquer

http://www.w3.org/2001/XMLSchema#string

Jeffrey H Ruth

http://www.w3.org/2001/XMLSchema#string

Kevin Kwan

http://www.w3.org/2001/XMLSchema#string

Phillip L Campbell

http://www.w3.org/2001/XMLSchema#string

Salahuddin Ahmed

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals

Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130

Induction of full-length survival motor neuron by polyphenol botanical compounds

Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders

HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer

Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses

Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors

Angiogenesis and arthritis.

Amelioration of rat adjuvant-induced arthritis by Met-RANTES.

Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice.

P304

14692-14697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0802675105

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23262425

http://www.w3.org/2001/XMLSchema#string

P698

18796608

http://www.w3.org/2001/XMLSchema#string

P932

2567200

http://www.w3.org/2001/XMLSchema#string